Case Report

Is Thymoglobulin or Rituximab the Cause of This Serum Sickness? A Case Report of Serum Sickness Dilemma and Literature Review

Table 1

Monoclonal and polyclonal antibody-associated serum sickness and acute kidney injury case reports and treatment modalities.

AuthorPatient CharacteristicsAntibodies Used (ATG, ATGAM, or Rituximab)Indication of AntibodiesTreatment UsedCause of AKI and MethodsSpecific treatment for AKI if Any

Snow et al. [6]48-year-old female with CRTRabbit-ATGInductionPrednisone 60 mg PO/day for 2 daysUnknownConservative

Pham et al. [7]Female with LRTRabbit-ATGAcute Cellular RejectionTPE 2 treatmentsUnknownConservative

32-year-old male with CRTRabbit-ATGInduction or Acute Cellular Rejection1 mg/kg/day oral Prednisone or 2 mg/kg/day for 2 days Followed by TPE 1-2 treatmentsUnknownConservative
60-year-old male with CRTATGAMInduction or Acute Cellular RejectionAs AboveUnknownConservative
Tanriover et al. [4]31-year-old male with CRTRabbit-ATGInduction or Acute Cellular RejectionAs AboveN/AN/A
41-year-old male with LTRabbit-ATGInduction or Acute Cellular RejectionAs AboveUnknownConservative
39-year-old Female with CRTRabbit-ATGInduction or Acute Cellular RejectionAs AboveN/AN/A

Da Silva et al. [8]10-year-old female with aplastic anemiaRabbit-ATGAplastic Anemia30 mg/kg/day of Methylprednisone for 3 days followed by prednisone taperUnknownPeritoneal Dialysis for 14 days

Boothpur et al. [9] 24-year-old female with LURTRabbit-ATGInductionTPE and Methylprednisone 500 mg IV for 2 dosesN/AN/A
20-year-old female with LURTRabbit-ATGInductionTPE 3 treatmentsN/AN/A
37-year-old male LURTRabbit-ATGInductionTPE 2 treatmentsN/AN/A
51-year-old male with LRTRabbit-ATGInductionMethylprednisone 500 mg IV unknown doses followed by prednisone taperN/AN/A

Andresdottir et al. [10]51-year-old male with kidney transplantHorse-ATGInductionUnknown Endocapillary Glomerulonephritis on Kidney biopsyConservative

Lundquist et al. [11]45-year-old female with Liver TransplantRabbit-ATGInductionMethylprednisone 250 mg (3 mg/kg/day) 3 dosesUnknownConservative

Disperati et al. [12]52-year-old female with follicular lymphomaRituximabStage IV Follicular LymphomaIV Methylprednisone of unknown dose N/AN/A

DeMonaco and Jacobs [13]47-year-old female with follicular lymphomaRituximabFollicular LymphomaHigh dose corticosteroids followed by 10-day prednisone taper that failed. Then unknown doses of prednisone and indomethacinN/AN/A

D’Arcy and Mannik [14]45-year-old male with refractory autoimmune polyneuropathyRituximabRefractory Autoimmune PolyneuropathyPulse corticosteroids of unknown dosesN/AN/A

Herishanu [15]48-year-old female with refractory immune thrombocytopeniaRituximabRefractory Immune ThrombocytopeniaMethylprednisone 500 mg IV 2 daysN/AN/A

Hellerstedt and Ahmed [16]23-year-old female with LupusRituximabAutoimmune ThrombocytopeniaSteroid bolus of unknown dosesN/AN/A

Todd and Helfgott [1]68-year-old male with stage 2A mantle cell lymphomaRituximabTreatment for Mantle Cell LymphomaIntra-articular Methylprednisone 80 mg and Oral prednisone 20 mg daily followed by Prednisone taper for 4 weeksN/AN/A

Sandhu et al.51-year-old male with CRTRabbit-ATG and RituximabAcute Cellular RejectionSoluMedrol 500 mg IV 3 daysAcute Tubular Necrosis findings on Urine MicroscopyConservative

*ATG: antithymocyte globulin; ATGAM: antithymocyte globulin or lymphocyte immune globulin; TPE: therapeutic plasma exchange; CRT: cadaveric renal transplant; LRT: living-related transplant; LURT: living-unrelated transplant; IV: intravenous.